Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 5057-5067
Publisher
Informa UK Limited
Online
2020-06-08
DOI
10.2147/ott.s237474
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer
- (2019) Mingkun Jiang et al. Cell Death & Disease
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis
- (2018) Dengfeng Li et al. CANCER LETTERS
- Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway
- (2018) Xueran Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SMAD specific E3 ubiquitin protein ligase�1 promotes ovarian cancer cell migration and invasion via the activation of the RhoA/ROCK signaling pathway
- (2018) Wei Wang et al. ONCOLOGY REPORTS
- Inhibition of EZH2 and EGFR produces a synergistic effect on cell apoptosis by increasing autophagy in gastric cancer cells
- (2018) Youping Yang et al. OncoTargets and Therapy
- TRIM37 promotes cell invasion and metastasis by regulating SIP1-mediated epithelial–mesenchymal transition in gastric cancer
- (2018) Dehu Chen et al. OncoTargets and Therapy
- Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity
- (2017) Laurel T. Bate-Eya et al. EUROPEAN JOURNAL OF CANCER
- Raf-1/CK2 and RhoA/ROCK signaling promote TNF-α-mediated endothelial apoptosis via regulating vimentin cytoskeleton
- (2017) Lifeng Yang et al. TOXICOLOGY
- The novel EZH2 inhibitor, GSK126, suppresses cell migration and angiogenesis via down-regulating VEGF-A
- (2016) Ya-Tian Chen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Regulation of the RhoA/ROCK/AKT/β-catenin pathway by arginine-specific ADP-ribosytransferases 1 promotes migration and epithelial-mesenchymal transition in colon carcinoma
- (2016) Guang-Lin Song et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular targeted therapy for the treatment of gastric cancer
- (2016) Wenting Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Diosgenin induces ROS-dependent autophagy and cytotoxicity via mTOR signaling pathway in chronic myeloid leukemia cells
- (2016) Shanshan Jiang et al. PHYTOMEDICINE
- Small molecule epigenetic screen identifies novel EZH2 and HDAC inhibitors that target glioblastoma brain tumor-initiating cells
- (2016) Natalie Grinshtein et al. Oncotarget
- Large variety in a panel of human colon cancer organoids in response to EZH2 inhibition
- (2016) Martijn AJ Koppens et al. Oncotarget
- Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells
- (2016) Delong Zeng et al. Oncotarget
- Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
- (2016) Changyuan Wang et al. Scientific Reports
- Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma
- (2015) Mehnaz Khan et al. LABORATORY INVESTIGATION
- EZH2 inhibition enhances the efficacy of an EGFR inhibitor in suppressing colon cancer cells
- (2014) Bryson W Katona et al. CANCER BIOLOGY & THERAPY
- Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition
- (2014) SHIHORI TANABE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting histone methyltransferase EZH2 as cancer treatment
- (2014) Y. Kondo JOURNAL OF BIOCHEMISTRY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Diosgenin inhibits the migration of human breast cancer MDA-MB-231 cells by suppressing Vav2 activity
- (2014) Zhongmei He et al. PHYTOMEDICINE
- Dioscin, a natural steroid saponin, induces apoptosis and DNA damage through reactive oxygen species: A potential new drug for treatment of glioblastoma multiforme
- (2013) Linlin Lv et al. FOOD AND CHEMICAL TOXICOLOGY
- Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
- (2013) S. K. Knutson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-Proliferation and Anti-Invasion Effects of Diosgenin on Gastric Cancer BGC-823 Cells with HIF-1α shRNAs
- (2012) Zhu-Jun Mao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
- (2012) Irfan A. Asangani et al. MOLECULAR CELL
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Antineoplastic and Apoptotic Potential of Traditional Medicines Thymoquinone and Diosgenin in Squamous Cell Carcinoma
- (2012) Subhasis Das et al. PLoS One
- Diosgenin induces death receptor-5 through activation of p38 pathway and promotes TRAIL-induced apoptosis in colon cancer cells
- (2010) C. Lepage et al. CANCER LETTERS
- Epithelial–mesenchymal transition of rat peritoneal mesothelial cells via Rhoa/Rock pathway
- (2010) Hao Zhang et al. IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL
- RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
- (2008) F. Peng et al. DIABETES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started